5HT2 receptors, depression and anxiety - PubMed (original) (raw)
5HT2 receptors, depression and anxiety
J F Deakin. Pharmacol Biochem Behav. 1988 Apr.
Abstract
The distinction between non-psychotic repressive illness and anxiety states is blurred. Large scale trials in the neuroses indicate that benzodiazepines are ineffective in depression, and transiently and partially effective in anxiety. In contrast, tricyclic antidepressants are effective in both. All effective antidepressants decrease 5HT2 receptors number and this may mediate antidepressant efficacy. Our studies indicate that reduction of 5HT2 relative to 5HT1 neurotransmission would reverse the neuroendocrine abnormalities we have described in depression. Reduced 5HT2 neurotransmission may also be a mechanism of anxiolytic action in view of 5HT theories of punishment. There is clinical evidence for anxiolytic and antidepressant action of selective 5HT2 antagonists.
Similar articles
- Neuroendocrine markers of serotonin responsivity in depression.
Stahl SM. Stahl SM. Prog Neuropsychopharmacol Biol Psychiatry. 1992 Sep;16(5):655-9. doi: 10.1016/0278-5846(92)90022-7. Prog Neuropsychopharmacol Biol Psychiatry. 1992. PMID: 1496123 - Recent developments in 5HT-related pharmacology of animal models of anxiety.
Gardner CR. Gardner CR. Pharmacol Biochem Behav. 1986 May;24(5):1479-85. doi: 10.1016/0091-3057(86)90215-7. Pharmacol Biochem Behav. 1986. PMID: 2873594 - Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
Leonhardt S, Gorospe E, Hoffman BJ, Teitler M. Leonhardt S, et al. Mol Pharmacol. 1992 Aug;42(2):328-35. Mol Pharmacol. 1992. PMID: 1355262 - Depression and 5HT.
Deakin JF. Deakin JF. Int Clin Psychopharmacol. 1991 Dec;6 Suppl 3:23-8; discussion 29-31. doi: 10.1097/00004850-199112003-00002. Int Clin Psychopharmacol. 1991. PMID: 1806632 Review. - Serotonin: a common neurobiologic substrate in anxiety and depression.
Eison MS. Eison MS. J Clin Psychopharmacol. 1990 Jun;10(3 Suppl):26S-30S. J Clin Psychopharmacol. 1990. PMID: 2198299 Review.
Cited by
- 5-HT1A partial agonists. What is their future?
Glitz DA, Pohl R. Glitz DA, et al. Drugs. 1991 Jan;41(1):11-8. doi: 10.2165/00003495-199141010-00002. Drugs. 1991. PMID: 1706983 Review. No abstract available. - Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
Tan H, Zhong P, Yan Z. Tan H, et al. J Neurosci. 2004 May 26;24(21):5000-8. doi: 10.1523/JNEUROSCI.0143-04.2004. J Neurosci. 2004. PMID: 15163692 Free PMC article. - Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications.
Yan Z. Yan Z. Mol Neurobiol. 2002 Oct-Dec;26(2-3):203-16. doi: 10.1385/MN:26:2-3:203. Mol Neurobiol. 2002. PMID: 12428756 Review. - Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice.
Bourin M, Hascoët M, Colombel MC, Coutts RT, Baker GB. Bourin M, et al. J Psychiatry Neurosci. 2002 May;27(3):178-85. J Psychiatry Neurosci. 2002. PMID: 12066447 Free PMC article. - Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.
Bambico FR, Cassano T, Dominguez-Lopez S, Katz N, Walker CD, Piomelli D, Gobbi G. Bambico FR, et al. Neuropsychopharmacology. 2010 Sep;35(10):2083-100. doi: 10.1038/npp.2010.80. Epub 2010 Jun 23. Neuropsychopharmacology. 2010. PMID: 20571484 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical